0000011941 00000 n
Get the latest Stockhead news delivered free to your inbox. Throughout FY18 Nanosonics continued to make strategic investments in several new product developments. Nanosonics' activities from product design, manufacturing, packaging and operations are focused on the dual objectives. Active, ClosedWhether an Organization is for profit or non-profit Additionally, its strong product innovation could position Nanosonics as a world leader in infection prevention. We usually like to see fairly high levels of insider ownership. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.It doesn't really mean much that no insider has traded Nanosonics shares in the last quarter. 0000012175 00000 n
xref
Nanosonics' activities from product design, manufacturing, packaging and operations are focused on the dual objectives.Nanosonics develops high-tech solutions for infection control. A company is also exposed to the risk of medical and technological advancement by competitors where alternative products or methods are developed and commercialized that will render Trophon obsolete.To address this risk, the company has invested in R&D for the second generation of Trophon, trophon2 which was released to the market in August 2018, and continues to invest heavily in product diversification.The company relies heavily on its ability to maintain and protect its intellectual property (IP) including registered and unregistered IP. Search Crunchbase. Also, some customers deferring purchase pending launch of … The new version of product Trophon2 receives regulatory approvals in the USA, Canada, and Europe.As a medical device company, Quality Management System (QMS) is paramount to Nanosonics. Solutions. Nanosonics continues to expand and entered into a new capital reseller agreement with The upgrade market is expected to commence, especially for existing units that are five years or older. For investors, getting access to the right information is critical. SaaS, Android, Cloud Computing, Medical Device)Where the organization is headquartered (e.g. <<75D105894835DD4283DF6AF47D1DED9D>]>>
89 32
These stocks represent some of the best value the ASX has to offer. Although most of the threats the company has the strategy to manage the risk, there are still some other problems, for example, the regulations applied in different countries and single market reliance.Nanosonics shares (ASX NAN) relies heavily on the US market, and this is where 89.62% of the revenue is generated from. 0000023955 00000 n
Nanosonics develops high-tech solutions for infection control. Nanosonics is a very promising business in the infection control market, with its Trophon product being the industry standard for ultrasound disinfection. 0000009619 00000 n
These models include Capital equipment sales (Direct), Capital equipment rentals (Direct), Managed Equipment Service model (Direct), Ultrasound Capital Reseller model and Distribution model.Nanosonics continues to be innovative and invest in product expansion with significant research and engineering capability. Xerox and Inozyme See Activist Action . Making it easy for our investors and potential investors to access the latest shareholder and company information is important to us. He has worked as a Trader, Adviser and Senior Manager.Download the Top 5 ASX stocks to buy for 2020 here. This provides the opportunity to continue growing and expanding geographically.Total sales of Nanosonics shares reflect a 10% reduction in capital revenue on the prior year, Nanosonics points out that this is associated with the earlier than anticipated regulatory approval of trophon2 with North America and European, and subsequent run down of Trophon EPR (the first generation) inventory by distributors. If you want to know exactly who sold, for how much, and when, simply click on the graph below!There are plenty of other companies that have insiders buying up shares. 0000029683 00000 n
Our research team has worked hard to uncover 5 stocks that either has growth potential or are undervalued. Nanosonics.